NCT03492541 Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease Status COMPLETED Phase NA
NCT03467490 Self-care Management Program for Dry Eye Disease Patients Using the heiQ Status UNKNOWN Phase NA
NCT03452397 Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study) Status COMPLETED Phase PHASE2
NCT03292809 CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) Status COMPLETED Phase PHASE2/PHASE3
NCT03291704 Investigating the Effect of At Home Thermal Therapy on Dry Eye Patients With Meibomian Gland Dysfunction Status UNKNOWN Phase NA
NCT03287635 Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE4
NCT03216096 Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease Status COMPLETED Phase PHASE1
NCT03108664 HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) Status COMPLETED Phase PHASE3
NCT03048526 Influence of Perfluorohexyloctane (NovaTears) on Tear Film Thickness in Patients With Mild to Moderate Dry Eye Disease Status COMPLETED Phase NA
NCT02943382 Fingerprick Autologous Blood (FAB) in Mebomian Gland Dysfunction (MGD) Status UNKNOWN Phase NA
NCT02848222 Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens Wearers Status COMPLETED Phase NA
NCT02831387 Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Status TERMINATED Phase PHASE2
NCT02824913 Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Status TERMINATED Phase PHASE2
NCT02764814 In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye Status COMPLETED Phase NA
NCT02284516 A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) Status COMPLETED Phase PHASE3
NCT02260960 The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease Status COMPLETED Phase PHASE2/PHASE3
NCT02254265 Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca Status COMPLETED Phase PHASE2/PHASE3
NCT02242032 Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE1
NCT02120079 The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED Status COMPLETED Phase PHASE4